News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient
Kinetic Profiling
Sep 6, 2024, 09:54

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient

JCO Precision Oncology made the following post on X:

“Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.”

Authors: Florence T.H. Wu, James T. Topham, Chris J. O’Callaghan, Harriet Feilotter, Hagen F. Kennecke, Leylah Drusbosky, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree.

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient

Source: JCO Precision Oncology/X

Canadian Cancer Trials Group CO.26 Trial cancer Chris J. O'Callaghan Circulating tumor DNA Daniel J Renouf Derek J. Jonker Dongsheng Tu Eric X. Chen Florence T.H. Wu Hagen F.Kennecke Harriet Feilotter James T. Topham Jonathan M. Loree Leylah Drusbosky Metastatic colorectal cancer OncoDaily Oncology RAS mutations
Special Coverage
Science
May 9, 2025, 14:53
Sitna Ali Mwanzi: Navigation helps Cancer Patients Start, Continue and Complete Treatment
Insight
May 9, 2025, 14:48
Exploring PD-L1 in Oral Cavity Cancers: Insights from a Tertiary Care Audit in India - IJSO
Blog
May 9, 2025, 14:34
Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Blog
May 9, 2025, 14:19
Josh Thomas Georgy Highlights DESTINY-Breast11 Results in High-Risk HER2+ Early Breast Cancer
Blog
May 9, 2025, 14:18
Half of Patients Diagnosed With Cancer in 2023 Had a History of Smoking - CRI
Blog
May 9, 2025, 14:08
Aligning Incentives for Value-Based Success: Building Sustainable Oncology Partnerships - CancerX
Blog
May 9, 2025, 14:06
Childhood Cancer at Survivor’s Week 2025: A Celebration of Strength and New Beginnings
Blog
May 9, 2025, 14:01
Meet the ASCO25 Featured Voices
Blog
May 9, 2025, 13:59
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support
Insight
May 9, 2025, 13:55
FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot
Blog
May 9, 2025, 13:49
Fernando Goldsztein: A Time to Raise Awareness about Brain Tumors
Blog
May 9, 2025, 13:46
Small Cell Lung Cancer Progress: Insights from LUNGevity's Executive Director